Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis

Journal of Neuroimmunology

Volumn 234, Issue 1-2, 2011, Pages 155-160

  Li, Ying ^a   Wang, Honghao ^a   Long, Youming ^a   Lu, Zhengqi ^a   Hu, Xueqiang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Glucocorticoids; Immunological memory; Multiple sclerosis; Neuromyelitis optica; Th17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; MALE; MEMORY CELL; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH17 CELL;

ADULT; CYTOKINES; DISABILITY EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TH17 CELLS;

EID: 79955643472     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.03.009     Document Type: Article

References (15)

1. Haegele K.F., Stueckle C.A., Malin J.P., Sindern E. Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls. J. Neuroimmunol. 2007, 183:168-174.
2. Kolls J.K., Lindén A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
3. Liu H., Rohowsky-Kochan C. Regulation of IL-17 in human CCR6+ effector memory T cells. J. Immunol. 2008, 180:7948-7957.
4. Liu G.Z., Fang L.B., Hjelmström P., Gao X.G. Increased CD8+ central memory T cells in patients with multiple sclerosis. Mult. Scler. 2007, 13:149-155.
5. Liu M., Hu X., Wang Y., Peng F., Yang Y., Chen X., et al. Effect of high-dose methylprednisolone treatment on Th17 cells in patients with multiple sclerosis in relapse. Acta Neurol. Scand. 2009, 120:235-241.
6. Noble A. Review article: molecular signals and genetic reprogramming in peripheral T-cell differentiation. Immunology 2000, 101(3):289-299.
7. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
8. Pozzilli C., Marinelli F., Romano S., Bagnato F. Corticosteroids treatment. J. Neurol. Sci. 2004, 223:47-51.
9. Sallusto F., Lenig D., Förster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
10. Tesmer L.A., Lundy S.K., Sarkar S., Fox D.A. Th17 cells in human disease. Immunol. Rev. 2008, 223:87-113.
11. Thakker P., Leach M.W., Kuang W., Benoit S.E., Leonard J.P., Marusic S. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:2589-2598.
12. Watanabe S., Misu T., Miyazawa I., Nakashima I., Shiga Y., Fujihara K., et al. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult. Scler. 2007, 13(8):968-974.
13. Wingerchuk D.M. Diagnosis and treatment of neuromyelitis optica. Neurologist 2007, 13:2-11.
14. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
15. Zivadinov R., Rudick R.A., De Masi R., Nasuelli D., Ukmar M., Pozzi-Mucelli R.S., et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001, 57(7):1239-1247.